🔗 Permalink

Inventor profile of:

Claire Mégret

City:

Lyons

Country:

France

Published Applications:

Last publication date:

2026-02-17

Top Assignees for applications by Claire Mégret

The entities that hold a legal rights for patent applications filed by inventor Mégret Claire:

Flamel Ireland Limited 38 Dublin, Ireland

Recent patent applications by Mégret Claire

Claire Mégret from Lyons, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-17

US18141666

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#2 | 2025-11-25

US17966538

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#3 | 2025-05-13

US17731562

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#4 | 2025-01-23

US20250025437A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#5 | 2025-01-09

US20250009705A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#6 | 2025-01-09

US20250009704A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#7 | 2025-01-07

US17178117

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#8 | 2024-11-14

US20240374549A1

Human necessities

Modified release gamma- hydroxybutyrate formulations having improved pharmacokinetics

#9 | 2024-11-07

US20240366547A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#10 | 2024-10-31

US20240358667A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#11 | 2024-10-31

US20240358666A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#12 | 2024-10-29

US18643773

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#13 | 2024-07-11

US20240226051A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#14 | 2024-06-06

US20240180864A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#15 | 2024-06-06

US20240180863A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#16 | 2024-06-06

US20240180862A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#17 | 2024-06-06

US20240180861A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#18 | 2024-05-30

US20240173286A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#19 | 2024-05-23

US20240165068A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#20 | 2024-05-21

US17530096

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#21 | 2024-05-09

US20240148685A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#22 | 2024-04-04

US20240108594A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#23 | 2023-11-30

US20230381131A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#24 | 2023-10-10

US17666201

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#25 | 2023-06-08

US20230172893A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#26 | 2023-06-08

US20230172892A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#27 | 2023-03-14

US17497393

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#28 | 2023-03-14

US17497381

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#29 | 2023-02-21

US17666205

Human necessities

Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

#30 | 2022-11-22

US17497366

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#31 | 2021-06-24

US20210186916A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#32 | 2020-06-25

US20200197347A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#33 | 2019-09-19

US20190282532A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#34 | 2019-09-12

US20190274990A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#35 | 2019-09-05

US20190269641A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#36 | 2019-09-05

US20190269640A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#37 | 2019-06-20

US20190183836A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

#38 | 2018-01-25

US20180021284A1

Human necessities

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

InventorID:

6006581 ⎘